Get Healthy!

  • Posted June 25, 2026

GLP-1 Weight-Loss Boom Linked to Surge in Poison Control Calls

A new study found that calls to poison control centers involving popular GLP-1 weight-loss drugs climbed sharply after semaglutide was approved for obesity in 2021, with most cases linked to medication mistakes that could have been avoided.

Health News is provided as a service to Ashville / Circleville Apothecary site users by HealthDay. Ashville / Circleville Apothecary nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2026 HealthDay All Rights Reserved.

Share

Tags